Brivaracetam Differentially Affects Voltage‐Gated Sodium Currents Without Impairing Sustained Repetitive Firing in Neurons
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Summary: Aims: Brivaracetam (BRV) is an antiepileptic drug in Phase III clinical development.BRV binds to synaptic vesicle 2A (SV 2A) protein and is also suggested to inhibit voltage‐gated sodium channels (VGSC s). To evaluate whether the effect of BRV on VGSC s represents a relevant mechanism participating in its antiepileptic properties, we explored the pharmacology of BRV on VGSC s in different cell systems and tested its efficacy at reducing the sustained repetitive firing (SRF). Methods: Brivaracetam investigations on the voltage‐gated sodium current (I Na) were performed in N1E‐155 neuroblastoma cells, cultured rat cortical neurons, and adult mouse CA 1 neurons.SRF was measured in cultured cortical neurons and in CA 1 neurons. All BRV(100–300 μM) experiments were performed in comparison with 100 μM carbamazepine (CBZ). Results: Brivaracetam and CBZ reduced I Na in N1E‐115 cells (30% and 40%, respectively) and primary cortical neurons (21% and 47%, respectively) by modulating the fast‐inactivated state of VGSC s.BRV, in contrast to CBZ, did not affect I Na in CA 1 neurons and SRF in cortical and CA 1 neurons.CBZ consistently inhibited neuronal SRF by 75–93%. Conclusions: The lack of effect of BRV on SRF in neurons suggests that the reported inhibition of BRV on VGSC currents does not contribute to its antiepileptic properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
Lynch, B. A., Lambeng, N., Nocka, K., Kensel-Hammes, P., Bajjalieh, S. M., Matagne, A., & Fuks, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308208101 · Cited by 1,610 · cited 13×
“CNS Neuroscience & Therapeutics Published by John Wiley & Sons Ltd. Brivaracetam, a close analog of levetiracetam, was developed as a second generation SV2A ligand with improved binding properties to the SV2A protein.”
BackgroundInfluentialSynaptic vesicle protein 2A: basic facts and role in synaptic function
Mendoza‐Torreblanca, J. G., Vanoye‐Carlo, A., Phillips‐Farfán, B. V., Carmona‐Aparicio, L., & Gómez‐Lira, G. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12360 · Cited by 124
Levetiracetam Reverses Synaptic Deficits Produced by Overexpression of SV2A
Nowack, A., Malarkey, E. B., Yao, J., Bleckert, A., Hill, J., & Bajjalieh, S. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029560 · Cited by 81 · cited 1×
“LEV was demonstrated to act presynaptically by decreasing neurotransmitter release in an SV2A-dependent manner [37] and especially under conditions of sustained neuronal activity [12,13].”
Background
Cited by
Klitgaard, H., Matagne, A., Nicolas, J., Gillard, M., Lamberty, Y., De Ryck, M., Kaminski, R. M., Leclercq, K., Niespodziany, I., Wolff, C., et al. (2016) · Epilepsia · doi:10.1111/epi.13340 · Cited by 168
Self-citationA review of the pharmacology and clinical efficacy of brivaracetam
Klein, P., Diaz, A., Gasalla, T., & Whitesides, J. (2018) · Clinical Pharmacology: Advances and Applications · doi:10.2147/cpaa.s114072 · Cited by 99
“Importantly, BRV had no effect against sustained repetitive firing in these neurons, suggesting that BRV’s antiepileptic mechanism is unrelated to effects on voltage-gated sodium channels.(45,48,49)”
BackgroundWu, P.-P., Cao, B.-R., Tian, F.-Y., & Gao, Z.-B. (2024) · Neuroscience Bulletin · doi:10.1007/s12264-023-01138-2 · Cited by 35
Okada, M., Fukuyama, K., Shiroyama, T., & Ueda, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111462 · Cited by 28
Presynaptic antiseizure medications-basic mechanisms and clues for their rational combinations
Czapińska-Ciepiela, E. K., Łuszczki, J., Czapiński, P., Czuczwar, S. J., & Lasoń, W. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00603-7 · Cited by 13
Metadata
- Authors
- Niespodziany, I., André, V. M., Leclère, N., Hanon, E., Ghisdal, P., & Wolff, C.
- Venue
- CNS Neuroscience & Therapeutics
- Publisher
- Wiley
- Published
- 2014-12
- Volume
- 21
- Issue
- 3
- Pages
- 241-251
- ISSN
- 1755-5930 (ISSN-L)
- 1755-5949
- OpenAlex
- W2032960068
- Cited by
- 46
- References
- 3
- FWCI
- 2.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Brivaracetam Differentially Affects Voltage‐Gated Sodium Currents Without Impairing Sustained Repetitive Firing in Neurons. https://app.cochat.ai/papers/10.1111/cns.12347
- The paper
- Niespodziany, I., André, V. M., Leclère, N., Hanon, E., Ghisdal, P., & Wolff, C. (2015). Brivaracetam Differentially Affects Voltage‐Gated Sodium Currents Without Impairing Sustained Repetitive Firing in Neurons. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.12347
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.